GlaxoSmithKline under fire again on AIDS drugs
Date: 2 Jun 2002
GlaxoSmithKline is to be barred from marketing drugs at the outpatient sites of the AIDS Healthcare Foundation in protest at its pricing policies that the Foundation says put the company "outside the bounds of corporate responsibility".
The Foundation, one of the largest providers of specialised care for HIV patients in the US, hopes that the move will block the company's main channel to inform doctors directly about new products.Its complaint is that although the company offers reduced prices for AIDS drugs sold in the developing world it still charges twice as much as its competitors.GlaxoSmithKline has countered the charges, saying that it has reduced prices by as much as 90 percent and does not make profit on AIDS drugs sold in the developing world.
Article source: Washington Post / AP
You must be logged in to add comments
In a recent article, the BBC's economics editor Robert Peston highlighted the fact that in 2012 the chances are that the economy - punch drunk as it is from the various flavours of debt crisis it has been pummelled with over the course of the year - will be hit by the collapse of a major bank and / or government.
From the same country
Other stories about this company
Currently most popular stories